FTY720 (fingolimod) attenuates beta-amyloid peptide (Aβ42)-induced impairment of spatial learning and memory in rats (Q44826580)

6 December 2017

title

FTY720 (fingolimod) attenuates beta-amyloid peptide (Aβ42)-induced impairment of spatial learning and memory in rats (English)

1 reference

6 December 2017

5

1 reference

6 December 2017

Masoumeh Asle-Rousta

1

1 reference

6 December 2017

Zeynab Kolahdooz

series ordinal

2

1 reference

6 December 2017

Shahrbanoo Oryan

series ordinal

3

1 reference

6 December 2017

Abolhassan Ahmadiani

series ordinal

4

1 reference

6 December 2017

publication date

26 February 2013

1 reference

Journal of Molecular Neuroscience

6 December 2017

published in

1 reference

6 December 2017

volume

50

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

524-532

1 reference

Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Regulation of ceramide-induced neuronal death: cell metabolism meets neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

[The role of ceramides in selected brain pathologies: ischemia/hypoxia, Alzheimer disease].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Lipid mediators in the nucleus: Their potential contribution to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Critical role for sphingosine kinase-1 in regulating survival of neuroblastoma cells exposed to amyloid-beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Subcellular origin of sphingosine 1-phosphate is essential for its toxic effect in lyase-deficient neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Deregulation of sphingolipid metabolism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Physiology and pathophysiology of sphingolipid metabolism and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Fingolimod modulates microglial activation to augment markers of remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

The metabolism and function of sphingolipids and glycosphingolipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

FTY720 reduces post-ischemic brain lymphocyte influx but does not improve outcome in permanent murine cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Central nervous system-directed effects of FTY720 (fingolimod).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Sphingosine-1-phosphate induces apoptosis of cultured hippocampal neurons that requires protein phosphatases and activator protein-1 complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Anastrozole improved testosterone-induced impairment acquisition of spatial learning and memory in the hippocampal CA1 region in adult male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Alzheimer's disease amyloid beta-protein and synaptic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

The interaction of beta-amyloid protein with cellular membranes stimulates its own production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Reassessing the amyloid cascade hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Sphingosine 1-phosphate, a key cell signaling molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Fingolimod provides long-term protection in rodent models of cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Apoptosis in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-9979-6

Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway

21 January 2018

1 reference

12 December 2020

Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed

1 reference

12 December 2020

Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases

1 reference

12 December 2020

A review: inflammatory process in Alzheimer's disease, role of cytokines.

1 reference

12 December 2020

10.1007/S12031-013-9979-6

Identifiers

DOI

1 reference

6 December 2017

1 reference